tividenofusp alfa
DNLI-E-0008
Phase 3 small_molecule active
Quick answer
tividenofusp alfa for Mucopolysaccharidosis II is a Phase 3 program (small_molecule) at Denali Therapeutics with 3 ClinicalTrials.gov record(s).
Program details
- Company
- Denali Therapeutics
- Indication
- Mucopolysaccharidosis II
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active